HomeCOEPW • NASDAQ
add
Coeptis Therapeutics
Previous close
$0.020
Year range
$0.010 - $0.080
Market cap
8.00M USD
Avg Volume
29.58K
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.14M | -72.89% |
Net income | -1.83M | 71.20% |
Net profit margin | — | — |
Earnings per share | -0.05 | 76.61% |
EBITDA | -1.89M | 75.28% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.14M | -19.42% |
Total assets | 8.96M | 24.90% |
Total liabilities | 3.97M | 84.04% |
Total equity | 4.98M | — |
Shares outstanding | 41.12M | — |
Price to book | 0.17 | — |
Return on assets | -81.41% | — |
Return on capital | -130.09% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.83M | 71.20% |
Cash from operations | -1.89M | 3.36% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | 1.47M | 755.77% |
Net change in cash | -417.62K | 77.22% |
Free cash flow | -962.44K | 85.36% |
About
Founded
2017
Headquarters
Website
Employees
6
